1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Sleep Disorders-Pipeline Insights, 2014

Sleep Disorders-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Sleep Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Sleep Disorders. This report provides information on the therapeutic development based on the Sleep Disorders dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Sleep Disorders
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Sleep Disorders pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Sleep Disorders and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Sleep Disorders
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Sleep Disorders pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Sleep Disorders-Pipeline Insights, 2014
Table of Contents
- Sleep Disorders Overview
- Sleep Disorders Pipeline Therapeutics
- Sleep Disorders Therapeutics under Development by Companies
- Sleep Disorders Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Sleep Disorders Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Sleep Disorders Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Sleep Disorders Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Sleep Disorders - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Sleep Disorders - Discontinued Products
- Sleep Disorders - Dormant Products
- Companies Involved in Therapeutics Development for Sleep Disorders
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Sleep Disorders, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Sleep Disorders Assessment by Monotherapy Products
- Sleep Disorders Assessment by Combination Products
- Sleep Disorders Assessment by Route of Administration
- Sleep Disorders Assessment by Stage and Route of Administration
- Sleep Disorders Assessment by Molecule Type
- Sleep Disorders Assessment by Stage and Molecule Type
- Sleep Disorders Therapeutics - Discontinued Products
- Sleep Disorders Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Sleep Disorders, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Sleep Disorders Assessment by Monotherapy Products
- Sleep Disorders Assessment by Combination Products
- Sleep Disorders Assessment by Route of Administration
- Sleep Disorders Assessment by Stage and Route of Administration
- Sleep Disorders Assessment by Molecule Type
- Sleep Disorders Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sleep aids are pills and medical devices that enable a person suffering from sleep disorder to fall asleep. Sleep aids consist of various products such as medications, sleep laboratories, sleep apnea devices, ...

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Sleep aids are pills and medical devices which enable a person suffering from sleep disorder to fall asleep. They are used for diagnosis and treatment of sleep disorders and sleep disturbances. Sleep disorders ...

Consumer Health In The Us

September 2016 $ 2423

Consumer Health In Belgium

September 2016 $ 2423

Consumer Health In Austria

September 2016 $ 2423

Consumer Health In Canada

September 2016 $ 2423

Sleep Aids In Egypt

September 2016 $ 912

Sleep Aids In Morocco

September 2016 $ 912

Download Unlimited Documents from Trusted Public Sources

Sleep Aid Markets in Pakistan

  • August 2016
    9 pages
  • Sleep Aid  

  • Pakistan  

View report >

OTC Markets in the US

  • July 2016
    2 pages
  • OTC  

    Marketing Resea...  

    Dietary Supplem...  

  • United States  

View report >

Sleep Aid Markets in the US

  • June 2016
    9 pages
  • Sleep Aid  

    Cancer  

    Therapy  

  • United States  

View report >

Otc Markets In The Us

9 months ago

Otc Industry In The Us

9 months ago

Therapy Market In The Us

11 months ago

Related Market Segments :

Sleep Aid

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.